In a pair of transactions that underscore the rapid evolution of the fertility care and assisted reproduction landscape, IVI RMA North America has broadened its footprint in the United States through strategic partnerships with clinics in Iowa and New York City.
In the first of two transactions, completed Nov. 13, IVI RMA partnered with Mid-Iowa Fertility to increase patient access to top-tier fertility services across Iowa and the surrounding regions. Mid-Iowa Fertility is the only full-service fertility center in central Iowa.
In the second deal, closed Nov. 21, IVI RMA established a foothold in the New York City market through a new partnership with Island Reproductive Services, the only IVF clinic located on Staten Island. Island Reproductive Services will benefit from IVI RMA’s renowned research, lab expertise and operational scale.
Haynes Boone Mergers and Acquisitions Partner Brent Beckert and Healthcare and Life Sciences Co-Chair Jennifer Kreick led the transactions on behalf of the firm.
“These deals reflect both the strong and growing demand for reproductive health services and IVI RMA North America’s continued commitment to expanding access to patient-centered evidence-based fertility care,” Beckert said. “We are proud to support a client that is transforming the landscape of fertility care in the United States.”
Beckert and Kreick were supported by a multidisciplinary team, including:
- M&A Counsel Brett Moore and Associates Thomas Matteson and Janet Wyse
- FDA Regulatory and Compliance Counsel Kayla Cristales and Associate Luke Nguyen
- Healthcare and Life Sciences Associate Thomas Tanabe
- Labor and Employment Partner Raquel Alvarenga
- Real Estate Partner Brad Holdbrook and Associates Nick Beals and Maddie Ballard
- Employee Benefits Partner Scott Thompson and Attorney Courtney Benedict
- Partnership and Tax Partner Lauren White and Counsel Danielle Marr
- Environmental Partners Mary Mendoza and Clarissa Mills
With these acquisitions, IVI RMA strengthens its ability to deliver innovative, patient-centered fertility care in key regional markets, reinforcing its role as a leader in reproductive medicine.
Haynes Boone’s M&A Practice Group has comprehensive experience handling middle-market deals, having helped clients close more than 500 transactions in the last five years, with an aggregate value exceeding $50 billion. The firm’s Healthcare and Life Sciences Practice Group advises clients across the healthcare, biotechnology, pharmaceutical, medical device and health IT sectors on a wide range of matters, including business transactions, regulatory and compliance issues, Medicare/Medicaid reimbursement, HIPAA/HITECH privacy and data security, and healthcare investigations.
